Titlebook: Cytochrome P450; In Vitro Methods and Zhengyin Yan,Gary W. Caldwell Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus

Amalgam

书目名称Cytochrome P450影响因子(影响力)




书目名称Cytochrome P450影响因子(影响力)学科排名




书目名称Cytochrome P450网络公开度




书目名称Cytochrome P450网络公开度学科排名




书目名称Cytochrome P450被引频次




书目名称Cytochrome P450被引频次学科排名




书目名称Cytochrome P450年度引用




书目名称Cytochrome P450年度引用学科排名




书目名称Cytochrome P450读者反馈




书目名称Cytochrome P450读者反馈学科排名

fleeting

财产

Quantitative Determination of Cytochrome P450 Using LC-MS/MS,reclinical, and individual data to population pharmacokinetics. For example, quantitative proteomics data can be utilized for in vitro-in vivo extrapolation (IVIVE), in vitro model validation, and determination of interindividual and species differences. Here, we describe a detailed methodology for

resuscitation

Spectral Quantitation of Total Cytochrome P450 in Microsomes Using a Single-Beam Spectrophotometer,obtaining the difference spectrum of the reduced form of cytochrome P450 subtracted from the spectrum of the carbon monoxide bound, reduced form. The resulting spectrum can then be analyzed to determine the difference between the absorbance at 450 nm and an isosbestic value (usually at 490 nm). The

flourish

Cytochrome P450 Enzyme Kinetics: Km and Vmax Determinations Using Metabolite Formation and Substratst important drug metabolizing enzymes (DMEs), which are responsible for converting structurally diverse exogenous xenobiotics to more water-soluble form to facilitate excretion from the body. By understanding the basic principles of kinetic, function, and mechanism of CYP enzymes will help to deter

休战

Cytochrome P450 Inhibition Assay Using Human Liver Microsomes,y and development of new drugs, metabolic inhibitor drug interactions are important to consider since they can produce adverse effects. A robust LC/MS-based cytochrome P450 (CYP) inhibition assay using human liver microsomes has been fully developed and validated for major human CYPs, which could pr

休战

Evaluation of Time-Dependent Cytochrome P450 Inhibition Using the Area Under the Curve Shift Methodor drug–drug interactions (DDIs). DDIs occur when one drug affects the metabolism of a coadministered drug. This changes the exposure and clearance of a coadministered drug. The consequences are a risk of therapeutic efficacy of a drug to severe adverse drug reactions, leading to death. Thus, it is

gregarious

Assessing Cytochrome P450 Time-Dependent Inhibition (IC50 Shift Assay) Using Both Diluted and Non-D is usually studied by measuring the half-maximal inhibitory concentration (IC50) shift of a drug candidate after a 30-min incubation with human liver microsomes (HLMs) in the presence and absence of NADPH. There are two main methods to assess the IC50 shift, dilution method, and non-dilution method

certitude

碎石